Chyong N.

Chyong N. has an extensive work experience in the medical and pharmaceutical field. They currently work as a Medical Director at 4D Molecular Therapeutics since 2022. Prior to this, they held a similar position at Gemini Therapeutics from June 2021 to December 2021. Chyong N. also worked at Santen as a Director of Clinical Science from March 2020 to May 2021. Before that, they served as a Clinical Science Manager at Aerie Pharmaceuticals from 2018 to 2020. Additionally, Chyong N. worked as a Clinical Development Contractor at Allergan from 2016 to 2018. They held various roles in their earlier career, including Clinical Programs Principal Scientist at TearScience, Inc. from 2013 to 2014 and Manager of Clinical Affairs at OD-OS Inc from 2011 to 2013. Chyong N. also gained research experience as an Ophthalmology Research-Postdoctoral Scholar at Gavin Herbert Eye Institute from 2006 to 2011. They initially started their career as an Attending Ophthalmologist at Hospital Dr. Sotero del Rio and also worked in private practice as an Attending Ophthalmologist during the same time period from 2003 to 2006.

Chyong N. began their education in 1993 at Pontificia Universidad Católica de Chile where they pursued a degree in Medicine. Chyong successfully completed their Doctor of Medicine (MD) program in 1999. Subsequently, from 2000 to 2003, Chyong N. enrolled in the Ophthalmology Residency Program at Universidad de los Andes (CL). Unfortunately, the field of study for this program is not specified.